With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the world entered a phase of social restrictions which...

A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine...

A team of scientists from Brazil recently explored the abilities of the UK, South African, and Brazilian variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade host CD8+ T...

The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity—such as individuals receiving immune-suppressive drugs for autoimmune diseases—can become...

A team of researchers in the UK – namely, Ben Ansell (Oxford), Martin W. Bauer (LSE), Jane Gingrich (Oxford), and Jack Stilgoe (UCL) – recently conducted a two-wave survey on the hesitancy...

The coronavirus disease 2019 (COVID-19) pandemic continues to ravage worldwide, infecting over 118.15 million people. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection...

As new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, fueling the continued spread of the coronavirus disease 2019 (COVID-19) pandemic, a new study offers...

A large team of researchers affiliated with a host of institutions across the U.K. has found that most SARS-CoV-2 variants rarely persist through secondary transmissions. In their paper published in the...

Researchers in the United States say the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant – P.1 – that has recently emerged in Brazil shows a worrying level of resistance...

New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings...